The efficiency of clinical trials involving transplantation of multipotent mesenchymal stromal cells (MSCs) is often insufficient due to harsh conditions present within the target tissue including hypoxia, low nutrient supply as well as inflammatory reactions. This indicates the necessity for optimization of cell-based therapy approaches which might include either modification of the cell manufacturing process or specific cell pretreatment procedures prior to transplantation. Recent reports confirm evidence that the aggregation of MSCs into three-dimensional (3D) multicellular spheroids results in enhancement of the overall therapeutic potential of cells, by improving the anti-inflammatory and angiogenic properties, stemness and survival of MSCs after transplantation. Such an MSCs spheroid generation approach may open new opportunities for the enlargement of MSCs applications in clinical research and therapy. However, the unification and optimization of 3D spheroid generation techniques, including the selection of appropriate clinical-grade culture conditions and methods for their large-scale production, are still of great importance. The current review addresses questions regarding therapeutic-associated properties of 3D multicellular MSCs spheroids in vitro and during preclinical animal studies, with special attention to the possibilities of translating these research achievements toward further clinical manufacturing and applications.

Department of Biomaterials and Biophysical Methods Institute of Experimental Medicine AS CR v v i Vídeňská 1083 14220 Prague 4 Krč Czech Republic

Department of Neuroscience Charles University 2nd Faculty of Medicine 5 Uvalu 84 15006 Prague Czech Republic

Zobrazit více v PubMed

Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–7. doi: 10.1080/14653240600855905. PubMed DOI

Teixeira FG, Carvalho MM, Sousa N, Salgado AJ. Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration? Cell Mol Life Sci. 2013;70:3871–82. doi: 10.1007/s00018-013-1290-8. PubMed DOI PMC

Marquez-Curtis LA, Janowska-Wieczorek A, McGann LE, Elliott JAW. Mesenchymal stromal cells derived from various tissues: biological, clinical and cryopreservation aspects. Cryobiology. 2015;71:181–97. doi: 10.1016/j.cryobiol.2015.07.003. PubMed DOI

English K, French A, Wood KJ. Mesenchymal stromal cells: facilitators of successful transplantation? Cell Stem Cell. 2010;7:431–42. doi: 10.1016/j.stem.2010.09.009. PubMed DOI

Cesarz Z, Tamama K. Spheroid culture of mesenchymal stem cells. Stem Cells Int. 2016;2016:9176357. doi: 10.1155/2016/9176357. PubMed DOI PMC

Mueller-Klieser W. Three-dimensional cell cultures: from molecular mechanisms to clinical applications. Am J Physiol. 1997;273(4 Pt 1):C1109–23. PubMed

Bartosh TJ, Ylöstalo JH, Mohammadipoor A, Bazhanov N, Coble K, Claypool K, et al. Aggregation of human mesenchymal stromal cells (MSCs) into 3D spheroids enhances their antiinflammatory properties. Proc Natl Acad Sci U S A. 2010;107:13724–9. doi: 10.1073/pnas.1008117107. PubMed DOI PMC

Park IS, Rhie JW, Kim SH. A novel three-dimensional adipose-derived stem cell cluster for vascular regeneration in ischemic tissue. Cytotherapy. 2014;16:508–22. doi: 10.1016/j.jcyt.2013.08.011. PubMed DOI

Potapova IA, Brink PR, Cohen IS, Doronin SV. Culturing of human mesenchymal stem cells as three-dimensional aggregates induces functional expression of CXCR4 that regulates adhesion to endothelial cells. J Biol Chem. 2008;283:13100–7. doi: 10.1074/jbc.M800184200. PubMed DOI PMC

Bhang SH, Lee S, Shin J, Lee T, Kim B. Transplantation of cord blood mesenchymal stem cells as spheroids enhances vascularization. Tissue Eng Part A. 2012;18:2138–47. doi: 10.1089/ten.tea.2011.0640. PubMed DOI PMC

Cheng N-C, Wang S, Young T-H. The influence of spheroid formation of human adipose-derived stem cells on chitosan films on stemness and differentiation capabilities. Biomaterials. 2012;33:1748–58. doi: 10.1016/j.biomaterials.2011.11.049. PubMed DOI

Guo L, Zhou Y, Wang S, Wu Y. Epigenetic changes of mesenchymal stem cells in three-dimensional (3D) spheroids. J Cell Mol Med. 2014;18:2009–19. doi: 10.1111/jcmm.12336. PubMed DOI PMC

Potapova IA, Gaudette GR, Brink PR, Robinson RB, Rosen MR, Cohen IS, Doronin SV. Mesenchymal stem cells support migration, extracellular matrix invasion, proliferation, and survival of endothelial cells in vitro. Stem Cells. 2007;25:1761–8. doi: 10.1634/stemcells.2007-0022. PubMed DOI

Murphy KC, Fang SY, Leach JK. Human mesenchymal stem cell spheroids in fibrin hydrogels exhibit improved cell survival and potential for bone healing. Cell Tissue Res. 2014;357:91–9. doi: 10.1007/s00441-014-1830-z. PubMed DOI PMC

Lee EJ, Park SJ, Kang SK, Kim G-H, Kang H-J, Lee S-W, et al. Spherical bullet formation via E-cadherin promotes therapeutic potency of mesenchymal stem cells derived from human umbilical cord blood for myocardial infarction. Mol Ther. 2012;20:1424–33. doi: 10.1038/mt.2012.58. PubMed DOI PMC

Lee RH, Pulin AA, Seo MJ, Kota DJ, Ylostalo J, Larson BL, et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell. 2009;5:54–63. doi: 10.1016/j.stem.2009.05.003. PubMed DOI PMC

Ylostalo JH, Bartosh TJ, Tiblow A, Prockop DJ. Unique characteristics of human mesenchymal stromal/progenitor cells pre-activated in 3-dimensional cultures under different conditions. Cytotherapy. 2014;16:1486–500. doi: 10.1016/j.jcyt.2014.07.010. PubMed DOI PMC

Bartosh TJ, Ylöstalo JH, Bazhanov N, Kuhlman J, Prockop DJ. Dynamic compaction of human mesenchymal stem/precursor cells into spheres self-activates caspase-dependent IL1 signaling to enhance secretion of modulators of inflammation and immunity (PGE2, TSG6, and STC1) Stem Cells. 2013;31:2443–56. doi: 10.1002/stem.1499. PubMed DOI PMC

Zimmermann JA, McDevitt TC. Pre-conditioning mesenchymal stromal cell spheroids for immunomodulatory paracrine factor secretion. Cytotherapy. 2014;16:331–45. doi: 10.1016/j.jcyt.2013.09.004. PubMed DOI

Hsueh Y-Y, Chiang Y-L, Wu C-C, Lin S-C. Spheroid formation and neural induction in human adipose-derived stem cells on a chitosan-coated surface. Cells Tissues Organs. 2012;196:117–28. doi: 10.1159/000332045. PubMed DOI

Cipriano M, Freyer N, Knöspel F, Oliveira NG, Barcia R, Cruz PE, et al. Self-assembled 3D spheroids and hollow-fibre bioreactors improve MSC-derived hepatocyte-like cell maturation in vitro. Arch Toxicol. 2016;91(4):1815–32. doi: 10.1007/s00204-016-1838-0. PubMed DOI

Yeh H-Y, Liu B-H, Sieber M, Hsu S. Substrate-dependent gene regulation of self-assembled human MSC spheroids on chitosan membranes. BMC Genomics. 2014;15(1):10. doi: 10.1186/1471-2164-15-10. PubMed DOI PMC

Zhang Q, Nguyen AL, Shi S, Hill C, Wilder-Smith P, Krasieva TB, Le AD. Three-dimensional spheroid culture of human gingiva-derived mesenchymal stem cells enhances mitigation of chemotherapy-induced oral mucositis. Stem Cells Dev. 2012;21:937–47. doi: 10.1089/scd.2011.0252. PubMed DOI PMC

Tsai A-C, Liu Y, Yuan X, Ma T. Compaction, fusion, and functional activation of three-dimensional human mesenchymal stem cell aggregate. Tissue Eng Part A. 2015;21:1705–19. doi: 10.1089/ten.tea.2014.0314. PubMed DOI PMC

Sart S, Tsai A-C, Li Y, Ma T. Three-dimensional aggregates of mesenchymal stem cells: cellular mechanisms, biological properties, and applications. Tissue Eng Part B Rev. 2014;20:365–80. doi: 10.1089/ten.teb.2013.0537. PubMed DOI PMC

Follin B, Juhl M, Cohen S, Pedersen AE, Kastrup J, Ekblond A. Increased paracrine immunomodulatory potential of mesenchymal stromal cells in 3D culture. Tissue Eng Part B Rev. 2016;22:1–26. doi: 10.1089/ten.teb.2015.0532. PubMed DOI PMC

Kusuma GD, Carthew J, Lim R, Frith JE. Effect of the microenvironment on mesenchymal stem cell paracrine signaling: opportunities to engineer the therapeutic effect. Stem Cells Dev. 2017 PubMed

Baraniak PR, Cooke MT, Saeed R, Kinney MA, Fridley KM, McDevitt TC. Stiffening of human mesenchymal stem cell spheroid microenvironments induced by incorporation of gelatin microparticles. J Mech Behav Biomed Mater. 2012;11:63–71. doi: 10.1016/j.jmbbm.2012.02.018. PubMed DOI PMC

Abdeen AA, Weiss JB, Lee J, Kilian KA. Matrix composition and mechanics direct proangiogenic signaling from mesenchymal stem cells. Tissue Eng Part A. 2014;20:2737–45. doi: 10.1089/ten.tea.2013.0661. PubMed DOI PMC

McBeath R, Pirone DM, Nelson CM, Bhadriraju K, Chen CS. Cell shape, cytoskeletal tension, and RhoA regulate stem cell lineage commitment. Dev Cell. 2004;6:483–95. doi: 10.1016/S1534-5807(04)00075-9. PubMed DOI

Shin CS, Lecanda F, Sheikh S, Weitzmann L, Cheng SL, Civitelli R. Relative abundance of different cadherins defines differentiation of mesenchymal precursors into osteogenic, myogenic, or adipogenic pathways. J Cell Biochem. 2000;78:566–77. doi: 10.1002/1097-4644(20000915)78:4<566::AID-JCB6>3.0.CO;2-K. PubMed DOI

Bhang SH, Cho S-W, La W-G, Lee T-J, Yang HS, Sun A-Y, et al. Angiogenesis in ischemic tissue produced by spheroid grafting of human adipose-derived stromal cells. Biomaterials. 2011;32:2734–47. doi: 10.1016/j.biomaterials.2010.12.035. PubMed DOI

Murphy KC, Hung BP, Browne-Bourne S, Zhou D, Yeung J, Genetos DC, Leach JK. Measurement of oxygen tension within mesenchymal stem cell spheroids. J R Soc Interface. 2017;14. doi:10.1098/rsif.2016.0851. PubMed PMC

Yang C-M, Huang Y-J, Hsu S-H. Enhanced autophagy of adipose-derived stem cells grown on chitosan substrates. Biores Open Access. 2015;4:89–96. doi: 10.1089/biores.2014.0032. PubMed DOI PMC

Ma D, Ren L, Liu Y, Chen F, Zhang J, Xue Z, Mao T. Engineering scaffold-free bone tissue using bone marrow stromal cell sheets. J Orthop Res. 2010;28:697–702. PubMed

Ma D, Zhong C, Yao H, Liu Y, Chen F, Li J, et al. Engineering injectable bone using bone marrow stromal cell aggregates. Stem Cells Dev. 2011;20:989–99. doi: 10.1089/scd.2010.0348. PubMed DOI

Suzuki S, Muneta T, Tsuji K, Ichinose S, Makino H, Umezawa A, Sekiya I. Properties and usefulness of aggregates of synovial mesenchymal stem cells as a source for cartilage regeneration. Arthritis Res Ther. 2012;14:R136. doi: 10.1186/ar3869. PubMed DOI PMC

Suenaga H, Furukawa KS, Suzuki Y, Takato T. Bone regeneration in calvarial defects in a rat model by implantation of human bone marrow-derived mesenchymal stromal cell spheroids. J Mater Sci Mater Med. 2015;26:1–9. doi: 10.1007/s10856-015-5591-3. PubMed DOI PMC

Lee JH, Han Y-S, Lee SH. Long-duration three-dimensional spheroid culture promotes angiogenic activities of adipose-derived mesenchymal stem cells. Biomol Ther (Seoul) 2016;24:260–7. doi: 10.4062/biomolther.2015.146. PubMed DOI PMC

Wang C-C, Chen C-H, Hwang S-M, Lin W-W, Huang C-H, Lee W-Y, et al. Spherically symmetric mesenchymal stromal cell bodies inherent with endogenous extracellular matrices for cellular cardiomyoplasty. Stem Cells. 2009;27:724–32. doi: 10.1634/stemcells.2008-0944. PubMed DOI

Emmert MY, Wolint P, Wickboldt N, Gemayel G, Weber B, Brokopp CE, et al. Human stem cell-based three-dimensional microtissues for advanced cardiac cell therapies. Biomaterials. 2013;34:6339–54. doi: 10.1016/j.biomaterials.2013.04.034. PubMed DOI

Liu B-H, Yeh H-Y, Lin Y-C, Wang M-H, Chen DC, Lee B-H, Hsu S-H. Spheroid formation and enhanced cardiomyogenic potential of adipose-derived stem cells grown on chitosan. Biores Open Access. 2013;2:28–39. doi: 10.1089/biores.2012.0285. PubMed DOI PMC

Amos PJ, Kapur SK, Stapor PC, Shang H, Bekiranov S, Khurgel M, et al. Human adipose-derived stromal cells accelerate diabetic wound healing: impact of cell formulation and delivery. Tissue Eng Part A. 2010;16:1595–606. doi: 10.1089/ten.tea.2009.0616. PubMed DOI PMC

Li Y, Guo G, Li L, Chen F, Bao J, Shi YJ, Bu H. Three-dimensional spheroid culture of human umbilical cord mesenchymal stem cells promotes cell yield and stemness maintenance. Cell Tissue Res. 2015;360:297–307. doi: 10.1007/s00441-014-2055-x. PubMed DOI

Talaei-Khozani T, Borhani-Haghighi M, Ayatollahi M, Vojdani Z. An in vitro model for hepatocyte-like cell differentiation from Wharton’s jelly derived-mesenchymal stem cells by cell-base aggregates. Gastroenterol Hepatol Bed Bench. 2015;8:188–99. PubMed PMC

Xu Y, Shi T, Xu A, Zhang L. 3D spheroid culture enhances survival and therapeutic capacities of MSCs injected into ischemic kidney. J Cell Mol Med. 2016;20:1203–13. doi: 10.1111/jcmm.12651. PubMed DOI PMC

Sharma RR, Pollock K, Hubel A, McKenna D. Mesenchymal stem or stromal cells: a review of clinical applications and manufacturing practices. Transfusion. 2014;54:1418–37. doi: 10.1111/trf.12421. PubMed DOI PMC

Burnouf T, Strunk D, Koh MBC, Schallmoser K. Human platelet lysate: replacing fetal bovine serum as a gold standard for human cell propagation? Biomaterials. 2015;76:371–87. doi: 10.1016/j.biomaterials.2015.10.065. PubMed DOI

Zheng X, Baker H, Hancock WS, Fawaz F, McCaman M, Pungor E. Proteomic analysis for the assessment of different lots of fetal bovine serum as a raw material for cell culture. Part IV. Application of proteomics to the manufacture of biological drugs. Biotechnol Prog. 2006;22:1294–300. doi: 10.1021/bp060121o. PubMed DOI

Bartosh TJ, Ylostalo JH. Preparation of anti-inflammatory mesenchymal stem/precursor cells (MSCs) through sphere formation using hanging-drop culture technique. Curr Protoc Stem Cell Biol. 2014;28:2B.6. PubMed PMC

Seda Tiğli R, Karakeçili A, Gümüşderelioğlu M. In vitro characterization of chitosan scaffolds: influence of composition and deacetylation degree. J Mater Sci Mater Med. 2007;18:1665–74. doi: 10.1007/s10856-007-3066-x. PubMed DOI

Yeh H, Liu B, Hsu S. The calcium-dependent regulation of spheroid formation and cardiomyogenic differentiation for MSCs on chitosan membranes. Biomaterials. 2012;33:8943–54. doi: 10.1016/j.biomaterials.2012.08.069. PubMed DOI

Hsu S, Huang G. Substrate-dependent Wnt signaling in MSC differentiation within biomaterial-derived 3D spheroids. Biomaterials. 2013;34:4725–38. doi: 10.1016/j.biomaterials.2013.03.031. PubMed DOI

Messina A, Morelli S, Forgacs G, Barbieri G, Drioli E, De Bartolo L. Self-assembly of tissue spheroids on polymeric membranes. J Tissue Eng Regen Med. 2015 PubMed

Wang W, Itaka K, Ohba S, Nishiyama N, Chung U, Yamasaki Y, Kataoka K. 3D spheroid culture system on micropatterned substrates for improved differentiation efficiency of multipotent mesenchymal stem cells. Biomaterials. 2009;30:2705–15. doi: 10.1016/j.biomaterials.2009.01.030. PubMed DOI

Zhang K, Yan S, Li G, Cui L, Yin J. In-situ birth of MSCs multicellular spheroids in poly(L-glutamic acid)/chitosan scaffold for hyaline-like cartilage regeneration. Biomaterials. 2015;71:24–34. doi: 10.1016/j.biomaterials.2015.08.037. PubMed DOI

Lewis EEL, Wheadon H, Lewis N, Yang J, Mullin M, Hursthouse A, et al. A quiescent, regeneration-responsive tissue engineered mesenchymal stem cell bone marrow niche model via magnetic levitation. ACS Nano. 2016;10:8346–54. doi: 10.1021/acsnano.6b02841. PubMed DOI

Neto AI, Correia CR, Oliveira MB, Rial-Hermida MI, Alvarez-Lorenzo C, Reis RL, Mano JF. A novel hanging spherical drop system for the generation of cellular spheroids and high throughput combinatorial drug screening. Biomater Sci. 2015;3:581–5. doi: 10.1039/C4BM00411F. PubMed DOI

Tung Y-C, Hsiao AY, Allen SG, Torisawa Y, Ho M, Takayama S. High-throughput 3D spheroid culture and drug testing using a 384 hanging drop array. Analyst. 2011;136:473–8. doi: 10.1039/C0AN00609B. PubMed DOI PMC

Zhao Z, Gu J, Zhao Y, Guan Y, Zhu XX, Zhang Y. Hydrogel thin film with swelling-induced wrinkling patterns for high-throughput generation of multicellular spheroids. Biomacromolecules. 2014;15:3306–12. doi: 10.1021/bm500722g. PubMed DOI

Peptide-coated DNA nanostructures as a platform for control of lysosomal function in cells

Hypothermic Storage of 3D Cultured Multipotent Mesenchymal Stromal Cells for Regenerative Medicine Applications

Remote Actuation of Apoptosis in Liver Cancer Cells via Magneto-Mechanical Modulation of Iron Oxide Nanoparticles

Novel Cryopreservation Approach Providing Off-the-Shelf Availability of Human Multipotent Mesenchymal Stromal Cells for Clinical Applications

The Effect of Wharton Jelly-Derived Mesenchymal Stromal Cells and Their Conditioned Media in the Treatment of a Rat Spinal Cord Injury